Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Clear-cell metastatic renal cell carcinoma × LY2510924 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 2 Neoplasm Metastasis 2 Solid Tumor 1 Clear-cell metastatic renal cell carcinoma 1

Interventions

Sunitinib 4 pazopanib 2 Nivolumab 2 Ipilimumab 2 fludarabine 1 cabozantinib 1 atezolizumab 1 Specimen Handling 1 Magnetic Resonance Spectroscopy 1 LY2510924 1 Cyclophosphamide 1 CTLA-4 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01391130 2019-07-23

A Study of LY2510924 and Sunitinib in Patients With Metastatic Renal Cell Carcinoma

Eli Lilly and Company

Phase 2 Terminated

110 enrolled 14 charts

Clear-cell metastatic renal cell carcinoma, Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡